SCHEMBL18872001

SCHEMBL18872001

CC(=O)N1c2ccc(-c3ccc(C(=O)NCC(C)O)cc3)cc2CC[C@@H]1C

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 4/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ BRD4 O60885 4/20 0.39
▸ BRD2 P25440 4/20 0.39
▸ BRD3 Q15059 4/20 0.39
▸ PDK1 Q15118 7/20 0.39
▸ PDK2 Q15119 7/20 0.39
▸ PDK3 Q15120 7/20 0.39
▸ PDK4 Q16654 7/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ HRH1 P35367 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18871776 0.85 NPC1 (0.44) NPC1ALDH1A1HTTRAB9ABRD4
SCHEMBL18871841 0.84 NPC1 (0.43) NPC1ALDH1A1HTTRAB9ABRD4
SCHEMBL18871830 0.84 MAPK14 (0.47) NPC1ALDH1A1HTTRAB9ABRD4
SCHEMBL26072650 0.83 WDR5 (0.42) NPC1ALDH1A1HTTRAB9ABRD4
SCHEMBL18871826 0.83 PDK1 (0.44) NAMPTNPC1ALDH1A1HTTRAB9A
SCHEMBL18871846 0.82 ALDH1A1 (0.41) NPC1ALDH1A1HTTRAB9ABRD4
SCHEMBL27266042 0.82 DRD2 (0.42) NPC1ALDH1A1HTTRAB9ABRD4
SCHEMBL14756761 0.82 PDK1 (0.45) NPC1ALDH1A1HTTRAB9ABRD4
SCHEMBL14756175 0.82 BRD4 (0.56) ALDH1A1HTTBRD4BRD2BRD3
SCHEMBL26071914 0.81 CYP11B1 (0.47) NPC1ALDH1A1HTTRAB9ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3168213-A1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS Glaxosmithkline LLC (US) 2017-05-17 — — EP disclosed
Send feedback